Average Co-Inventor Count = 5.10
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Fremont Inc. (11 from 78 patents)
2. Nextbio (7 from 7 patents)
18 patents:
1. 11492411 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
2. 10508153 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
3. 10275711 - System and method for scientific information knowledge management
4. 10127353 - Method and systems for querying sequence-centric scientific information
5. 10118968 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
6. 9633166 - Sequence-centric scientific information management
7. 9183349 - Sequence-centric scientific information management
8. 9141913 - Categorization and filtering of scientific data
9. 9096672 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
10. 9085624 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
11. 9073998 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
12. 9062113 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
13. 8364665 - Directional expression-based scientific information knowledge management
14. 8275737 - System and method for scientific information knowledge management
15. 8101178 - Antibodies directed to tumor necrosis factor and uses thereof